Abbott to Create 100 New Jobs in Dallas with US Expansion
|
Abbott Laboratories will be expanding its U.S. operations, with Dallas set to gain 100 new jobs as part of the company’s strategic push. The investment will strengthen manufacturing and research capabilities, particularly in the critical area of transfusion diagnostics. While acknowledging the financial impact of tariffs, Abbott’s leadership emphasized a long-term vision focused on resilience, innovation, and growth in key U.S. markets like Dallas and Illinois.
|
Novartis Expands US Manufacturing
with New Sites in Texas and Across the Country
|
Novartis will invest over five years to expand its U.S.-based manufacturing and R&D operations, with the goal of producing 100% of its key medicines domestically. The plan includes developing 10 facilities—seven of them brand new—and is expected to create nearly 5,000 jobs nationwide. Among the new sites are two radioligand therapy manufacturing facilities, including one in Texas, as well as a biomedical research hub in San Diego.
|
Renibus Therapeutics Completes Enrollment
in PROTECT Phase 3 Trial of RBT-1
|
Renibus Therapeutics® has completed enrollment in its PROTECT Phase 3 trial (n=423) evaluating RBT-1 for reducing post-operative complications in cardiac surgery patients. The trial, conducted across 40 sites in the US and Canada, expects topline results in Q3 2025. RBT-1, a first-in-class preconditioning agent, has previously shown positive Phase 2 results and holds Breakthrough Therapy and Fast Track Designations from the FDA. Renibus aims to address a critical unmet need in reducing complications following cardiac surgery.
|
Leading Fort Worth Into the Future:
Innovation with Mayor Mattie Parker
|
With over 20 years of experience in law and public service, Mayor Parker has played a key role in shaping Fort Worth's development. From her time as chief of staff for the Mayor and City Council to her leadership of local initiatives like Fort Worth Cradle to Career and the T3 Partnership, she has consistently worked to improve education, workforce opportunities, and public safety. As a visionary leader, she shares her perspective on the city’s innovative strides and outlines her bold plans to position Fort Worth as a national leader in innovation, ensuring continued growth and success for generations to come.
|
Frisco Station Partnership Breaks Ground on
New Health & Wellness District
|
The Frisco Station Partnership has officially broken ground on a new medical office building, marking the launch of the highly anticipated Health and Wellness District at Frisco Station.
Developed by Dallas-based Cambridge Holdings Incorporated, the 85,800-square-foot facility is scheduled to open in late 2026. It will serve as the first health-focused addition to the award-winning, 242-acre Frisco Station mixed-use development.
The facility will also feature a wet lab space.
|
Verily Awarded Michael J. Fox Foundation Grant
for Parkinson's Data
|
Parkinson’s disease remains a complex mystery, with symptoms that range from noticeable motor challenges to subtle molecular shifts. Understanding it requires looking at the full picture—including genetics, the immune system, and metabolism.
The Michael J. Fox Foundation has partnered with Verily for years to build a robust, publicly available data resource aimed at uncovering how these factors interact in Parkinson’s. Now, the Foundation is deepening its commitment with a new grant to Verily, Google’s life sciences arm.
|
Texas Needs Innovators: Advance Your Career
in Biotech and Life Sciences
|
Check out the new central hub for Biotech and Life Sciences roles across the state of Texas. Unlock your potential with a dynamic range of roles in biotech, engineering, and healthcare, and more. Whether you're launching your career or advancing to the next level, this job board connects you with top careers at the forefront of the state’s rapidly growing innovation ecosystem.
|
BHIANT Q2 Meeting Focuses on
Talent Development and Industry Collaboration
|
The Q2 BHIANT Meeting was held last week at Carter BloodCare's Corporate Office in Bedford, TX, bringing together industry leaders to share updates and align efforts around workforce development and resource accessibility. In support of BHIANT’s mission, attendees discussed ongoing training initiatives, funding sources for upskilling and apprenticeship programs, and best practices to introduce young students to the biotech and healthcare sectors.
At the beginning of the meeting, Dallas College announced the region was granted an extension by the EDA to continue funding the BioWorks training program. The College also announced the launch of the GoBiotech job board, which will serve as a central hub for connecting talent with job opportunities across the life sciences sector.
Thank you Carter BloodCare for hosting the meeting and showcasing their expertise with the BHIANT community.
|
TARSEC Workshop Showcases Texas Strength
in Aerospace and Space Medicine
|
(from left to right) Melinda Hailey, MSN, RN of Axiom Space, Kathleen Otto-Rosenblum of BioNTX,
Dorit Donoviel, PhD of Baylor College of Medicine & Head of TRISH, and Astronaut Serena Auñòn-Chancellor, MD, MPH, FACP of Texas A&M College of Medicine
|
The Texas Aerospace Research and Space Economy Consortium (TARSEC) hosted a workshop last week in Fort Worth, bringing together leaders from across academia, industry, and government to explore the future of the state’s space economy. With panels spanning topics such as space law, semiconductor innovation, space medicine, and workforce development, the workshop highlighted the critical role Texas plays in shaping the next frontier of space research and commercialization.
Among the organizations represented, BioNTX contributed to discussions on the emerging field of space medicine—underscoring the region’s growing capabilities in biomedical innovation and its potential to support human health beyond Earth’s atmosphere.
The workshop served as a platform for collaboration and knowledge-sharing that will help guide Texas’s strategic efforts in expanding its space-focused research and economic impact.
|
From Discovery to Impact:
Shaping the Life Science Ecosystem in Tyler
May 20, 2025
|
Join BioNTX on May 20th in Tyler, TX, for the second annual symposium focused on Building a Life Science Entrepreneurial Ecosystem. This event will highlight groundbreaking biomedical research and address crucial topics, including intellectual property, funding strategies, and entrepreneurial success. Attendees will gain valuable insights into the growth of the region’s life science industry and its role in shaping the future of healthcare and innovation.
|
Exploring Cutting-Edge Lab Solutions
at Pegasus Park with Avantor
June 4, 2025
|
Join BioNTX and Avantor at Pegasus Park for an exclusive opportunity to explore the latest advancements in research lab solutions tailored to your organization’s needs. This unique event will feature a dynamic showcase of vendors presenting cutting-edge tools and technologies that support every stage of research, development, and production.
Spanning industries from biotech to pharmaceuticals, these solutions are designed to drive greater efficiency, precision, and innovation. Don’t miss this chance to connect with industry leaders, discover what’s next in scientific advancement, and be part of the conversation shaping the future of research.
|
Building Tomorrow's Life Sciences Workforce:
Regional Collaborations for Success
June 11, 2025
|
North Texas is home to a thriving life sciences ecosystem, and the future looks even brighter with the growing talent pool. Join the BioNTX Facilities Committee as we explore how regional partnerships between manufacturers, higher education institutions, and K-12 STEM educators are shaping a workforce primed for success. This session will highlight the innovative efforts driving workforce development and positioning North Texas as a leader in life sciences.
|
Leverage Australia’s Advantage to
Accelerate Early-Phase Clinical Trials
June 25, 2025
|
Join BioNTX as we welcome an Australian delegation to Dallas. Discover how Australia’s fast regulatory process, quality systems, and cost incentives make it a top choice for early-phase clinical trials. Learn how engaging with Australia can accelerate your clinical trials.
|
Thank you for your support
|
iC³ SUMMIT NEWS & UPDATES
|
Save The Date: September 2025
|
The iC³ Life Science Summit is an event that brings together leaders and innovators from the life sciences and healthcare sectors to discuss challenges, discover new opportunities, and drive transformation.
As we look ahead to the 2025 iC³ Life Science & Healthcare Innovation Summit, we are celebrating “10 Years and Beyond” with a focus on the cutting-edge intersection of biology, technology, and artificial intelligence (AI). This convergence is powering breakthroughs in precision medicine, biomanufacturing, and other fields shaping the future of healthcare.
|
Dates
Tuesday, September 16: 7:00am - 7:00pm
Wednesday, September 17: 8:00am - 3:00pm
|
Location
Hilton Anatole
2201 N Stemmons Freeway, Dallas, TX 75207
|
Recognizing the Next Generation of
Life Science & Healthcare Innovators
Nominations due on July 1, 2025
|
BioNTX is proud to spotlight emerging leaders in life sciences and healthcare innovation through the Rising Stars program at the iC³ Summit. This program honors entrepreneurs, startups, and researchers making a significant impact.
Nominees should meet the following criteria:
- Emerging entrepreneurs
- Innovative startups & early-stage companies
- Researchers driving groundbreaking advancements
- Organizations with ≤ $100M in funding or sales
|
Carter Blood Care’s Vital Role in
Regional Health and Biomedical Research
|
For more than 70 years, Carter BloodCare, a nonprofit organization, has served as one of the largest blood centers in Texas. The comprehensive cellular therapy laboratory at Carter BloodCare has been entrusted to assist with the harvest (collection), processing, cryopreservation, storage, bedside thawing and infusion of cellular therapy products for patient infusion. We offer expertise with managing products for adult and pediatric transplant patients.
The laboratory strictly adheres to quality assurance processes, is registered with the FDA and is AABB accredited. In addition, it is one of the few cellular therapy labs in North Central Texas to be fully accredited by the Foundation for the Accreditation of Cellular Therapy.
|
Etira to Present Preclinical Data on
ERX-208 and ERX-315 at AACR 2025
|
Etira will present three abstracts featuring preclinical data on ERX-208 and ERX-315 at the American Association for Cancer Research (AACR) Annual Meeting 2025 in San Diego. These presentations will highlight ERX-208 as a promising breakthrough for ovarian cancer, demonstrate its synergy with FDA-approved therapies, and validate ERX-315—currently in a Phase 1 clinical trial for its potential in liver cancer.
|
GenrAb Secures Seed Financing to Advance
First-in-Class Neuroprotective Antibody Therapy
|
GenrAb, Inc., a developer of first-in-class neuroprotective therapies, has completed a Seed Financing round to support the development of its lead candidate, TGM-010, a novel, fully-human antibody for neurodegenerative diseases. By leveraging the human adaptive immune system, GenrAb has identified neuron-specific antibodies with the potential to reduce neurodegeneration. TGM-010 has demonstrated the ability to cross the blood-brain barrier, target neurons, and engage stress-response pathways to mitigate disability.
|
Nanoscope Therapeutics to Present at Eyecelerator
and ARVO 2025 Annual Meetings
|
Nanoscope Therapeutics Inc., a biotech company focused on restoring vision for blind patients, announced its participation at the Eyecelerator and ARVO 2025 annual meetings. The company will present 126-week outcomes from its MCO-010 optogenetic therapy for retinitis pigmentosa (RP), the first therapy to restore vision in advanced RP patients through a single intravitreal injection.
|
Spark Biomedical Advances Bioelectronic
Medicine Platform Following Series A Round
|
Spark Biomedical, a health tech innovator in wearable neurostimulation, has completed its Series A funding round to accelerate the development of its non-invasive bioelectronic therapies. Backed by WAVE Ventures and Pathway to Cures, Spark is expanding efforts in neurological health, hemostasis, and women’s health. The company’s technology delivers precise electrical pulses to stimulate the vagus and trigeminal nerves, offering drug-free, non-invasive support for a range of conditions. CEO Daniel Powell emphasized the milestone as a pivotal step in redefining how neurological conditions are treated—using targeted bioelectric solutions instead of pharmaceuticals.
|
DeSoto ISD Partners to Bring Real-World
Biotech Experience to the Classroom
|
DeSoto ISD, in partnership with Dallas College and Panthera BioSolutions, is launching a first-of-its-kind Pharmaceutical cGMP Fundamentals course at DeSoto High School, funded by the DeSoto Development Corporation (DDC). This innovative four-week program will transform the school’s chemistry lab into a hands-on training space simulating a pharmaceutical manufacturing environment, giving students early exposure to industry practices, compliance standards, and career pathways in North Texas’ growing life sciences sector. The course includes dual-enrollment opportunities through Dallas College, a site visit to Panthera’s cGMP facility in Fort Worth, and mentorship from pharmaceutical professionals, all aimed at preparing students for in-demand, high-skill jobs in biotech and pharma.
|
NIIMBL Launches New Projects to Advance
Biomanufacturing & Workforce Development
|
The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) has unveiled 11 new member-led projects totaling approximately $11.2 million through Project Call 8.1. These initiatives span technology innovation, workforce development, and global health, with the shared goal of strengthening domestic biopharmaceutical manufacturing capabilities.
Six of the projects focus on advancing key technologies identified by NIIMBL industry members, including improvements in manufacturing platforms, process analytical technologies, and data science and modeling. Three projects target workforce development by creating new tools and strategies to grow the biopharma talent pipeline, while two Global Health Fund projects—supported by the Gates Foundation—aim to reduce the cost of manufacturing mRNA-based preventative medical countermeasures.
|
EisnerAmper Partners Recognized on Forbes’
Inaugural “America’s Best-in-State CPAs” List
|
National business publication Forbes has announced its first-ever list of “America’s Best-in-State CPAs,” and several partners from leading business advisory firm EisnerAmper have been recognized among this elite group. The list, developed exclusively by Forbes editorial staff, highlights outstanding CPAs currently active in public practice.
Candidates were identified through independent nominations and recognition from various CPA associations. Selections were based on a range of criteria, including technical expertise, innovation, thought leadership, community service, and professional experience.
|
Harness IP Recognized as a Leading Firm for
US Patent and Trademark Filings in 2024
|
Harness IP is proud to announce its continued recognition in the 2024 Oppedahl toteboards, which rank law firms by the volume of U.S. patent and trademark registrations obtained for clients each year. The firm has earned a spot on the toteboards every year since their inception in 2012.
In 2024, Harness IP obtained 3,733 utility patents, securing second place in that category, where the firm has consistently ranked in the top ten since 2015. The firm also earned 15th place with 367 trademark registrations, 12th place with 118 design patents, and 4th place with one plant patent.
|
JLL Recognized for Global Leadership
in Advancing Healthy, Sustainable Buildings
|
JLL has received three prestigious awards from the International WELL Building Institute (IWBI) in 2024, highlighting its global leadership in creating healthier, more sustainable buildings. The firm was recognized for having the most WELL Accredited Professionals and WELL Faculty globally. JLL’s ongoing commitment to WELL certification continues to set the standard for health and sustainability in real estate, with over 105 million square feet of WELL-certified space delivered to date.
|
MJEC and ADW Corporation Unite to
Serve North Texas HVAC Market
|
McMillan James Equipment Company (MJEC) has acquired ADW Corporation, a well-established commercial HVAC manufacturers’ representative with nearly five decades of experience serving North Texas. The acquisition strengthens MJEC’s capabilities and expands its portfolio of HVAC solutions for building owners, architects, engineers, and contractors across the region. ADW, founded in 1950, brings deep industry knowledge and long-standing partnerships with leading manufacturers including Ruskin, Titus, and Cambridge.
|
RSM US Ranks #5 on Accounting Today's 2025 Top 100 Firms List
|
RSM US LLP has been ranked No. 5 on Accounting Today’s 2025 Top 100 Firms list, marking its 19th consecutive year on the prestigious list. The firm’s growth strategies, including expanding outsourced solutions, leading digital transformation efforts, and a focus on cybersecurity and AI, were highlighted in the report. RSM is also exploring a transatlantic merger with RSM UK to enhance global client offerings.
|
Baylor University Study Finds Digital Technology
May Help Prevent Cognitive Decline
|
Baylor University’s study on digital technology and cognitive aging challenges the idea that tech use accelerates dementia. Led by Michael K. Scullin, Ph.D., and Jared F. Benge, Ph.D., the research found that engaging with technology is linked to a 58% lower risk of cognitive impairment. The study highlights how learning new tech can provide cognitive challenges, improve social connections, and support independence through "digital scaffolding." Encouraging healthy tech use for older adults may help reduce dementia risks and boost cognitive health.
|
UNTHSC’s New Program Equips Public Health
Professionals with Essential Data Skills
|
The University of North Texas Health Science Center at Fort Worth is offering a new 15-credit-hour online graduate certificate in Geographic Information Systems (GIS). This program is designed to help public health professionals analyze spatial data and visualize health trends. The flexible, eight-week courses cover geospatial analysis, remote sensing, and data visualization, with applications now open for the summer term. Graduates will gain skills to apply GIS tools in real-world public health challenges, enhancing their career opportunities in research, practice, and leadership roles.
|
UTA Professor Inducted into Academy of
Distinguished Researchers for Innovation in Technology
|
Yuze “Alice” Sun, PhD, MS
|
Yuze “Alice” Sun, an electrical engineering professor at The University of Texas at Arlington (UTA), has been inducted into the Academy of Distinguished Researchers. This honor recognizes her groundbreaking work in photonics, nanotechnology, and biochemical sensing, which has advanced healthcare, environmental monitoring, and defense. Sun’s research has garnered over $8 million in funding, and she has published 90+ journal articles and secured three patents. Her work has been cited nearly 6,000 times, positioning her as a leading scholar in optofluidics.
|
UT Southwestern AI Model Predicts
Kidney Cancer Patients' Response to Therapy
|
UT Southwestern Medical Center researchers have developed an AI-based model that predicts which kidney cancer patients will benefit from anti-angiogenic therapy, a treatment effective for only some individuals.
Published in Nature Communications, this study uses histopathological slides – commonly available tumor tissue sections – to train a deep learning algorithm to assess blood vessel presence in kidney cancer tumors. The model’s results correlate closely with an existing, expensive test, Angioscore, but without its limitations like high cost and delayed treatment.
|
FUNDING & MENTORSHIP OPPORTUNITIES
|
NASA Translational Research Institute for Space Health (TRISH)
Program ends May 15, 2025
|
TRISH is an applied space health research catalyst that funds disruptive, high-impact research and technologies for astronauts. TRISH partners with NASA’s Human Research Program through a consortium led by Baylor College of Medicine’s Center for Space Medicine. Through this funding opportunity, TRISH seeks projects to help provide more accurate and precise ways of performing real-time non-invasive intracranial pressure monitoring for astronauts. Proposals must include non-invasive intracranial pressure estimation techniques to benchmark against existing methods with the goal of understanding their validity. Funded projects will undergo two consecutive phases. The first phase, the “Flight Definition Phase,” will consist of preparing for a potential flight on an orbital commercial spaceflight mission. The second phase, the “Flight Implementation Phase,” will provide support before, during, and after the flight.
|
Accelerating and Scaling Biological Sciences with AI
Next Application closes May 21, 2025
|
The Chan Zuckerberg Initiative (CZI) invites proposals to build large-scale AI/ML models that cannot be created with conventional university resources. CZI is the only philanthropic organization to fund and build one of the largest computing systems dedicated to nonprofit life sciences research in the world. CZI’s cluster is optimized for AI and machine learning training at scale and comprises 1,024 Nvidia H100 GPUs in an NVIDIA DGX SuperPOD configuration with access to VAST fast data storage.
This grant is for an allocation of CZI’s GPU resource (minimum request of 96 GPU). This is an in-kind award; there are no cash funds, financial contributions, or fees of any kind associated with the award.
Applications will be downloaded for consideration over the next third Wednesday of the month until June.
|
Grant Opportunity for Physician-Scientists:
Up to $2M Plus Expert Drug Development Support
Letter of Intent due June 4, 2025
|
Harrington Discovery Institute at University Hospitals is now accepting Letters of Intent for the 2026 Harrington Scholar-Innovator Award, which offers physician-scientists at accredited institutions in the U.S. and Canada a $100,000 guaranteed grant, expert drug and business development support, and the opportunity to compete for up to $300,000 in acceleration funds and up to $2 million in investment funding, while retaining intellectual property rights; Letters of Intent are due by June 4, 2025, with invited full applications due August 4, 2025.
|
Translating Research into Burn Solutions:
MBRP Technology/Therapeutic Development Award
Application closes June 23, 2025
|
The Military Burn Research Program (MBRP) Technology/Therapeutic Development Award (TTDA) supports the translation of preclinical burn research into practical products, such as medical devices, drugs, or clinical guidelines, for use in austere, resource-limited environments. This award focuses on developing tangible technologies or therapeutics to improve burn care in military and emergency response settings, with knowledge products that support these developments also eligible for funding.
|
Advancing Early-Stage Innovation in Rare Cancers
Application closes July 1, 2025
|
The Fiscal Year 2025 (FY25) Rare Cancers Research Program (RCRP) Idea Development Award (IDA) supports innovative, early-stage research ideas with the potential to generate impactful data and open new avenues for investigation.
|
Funding Bold Ideas to Advance
Duchenne Muscular Dystrophy Research
Letter of Intent due July 25, 2025
|
The FY25 Duchenne Muscular Dystrophy Research Program (DMDRP) Idea Development Award (IDA) is designed to spark bold, early-stage research with the potential to transform the landscape of Duchenne muscular dystrophy (DMD). This award supports high-risk, high-reward ideas that are conceptually innovative and could lead to groundbreaking discoveries or new research directions that significantly improve outcomes for individuals living with DMD.
|
Fueling the Next Generation of Health Innovators
Application closes March 6, 2026
|
The One Health Incubator is a dynamic partnership between the Innovation Hub and the Health Sciences Center, created to support researchers and technology startups in the life sciences sector. This collaborative platform combines institutional expertise to offer an ecosystem of incubation, mentorship, and strategic connections—tailored specifically for life science innovators.
Startups and researchers benefit from access to state-of-the-art facilities, specialized resources, and guidance from industry experts. The incubator helps accelerate the development and commercialization of innovative healthcare solutions while fostering valuable relationships with potential partners, investors, and mentors.
|
NIH Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions
Program ends January 8, 2027
|
The purpose of this Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions is to support small scale research grants at institutions that do not receive substantial funding from the NIH, with an emphasis on providing biomedical research experiences primarily for undergraduate students, and enhancing the research environment at applicant institutions.
|
Nominate a North Texas Life Sciences Leader
for the 2025 iC³ Dennis K. Stone Award
Nominations due on July 1, 2025
|
(from left to right) Kristin Lonergan, CIC of Champion Commercial Insurance and 2024 DKS recipient Jeff Keyser, PhD, RPh, JD of Renibus Therapeutics
|
BioNTX honors individuals who have made significant contributions to the North Texas biotechnology industry through the Dennis K. Stone Award. This recognition celebrates those who have advanced life science research and inspired others to do the same.
Nominees should meet the following criteria:
-
Industry Growth & Innovation: Contributed to the formation and growth of multiple North Texas-based life science businesses.
- Generosity: Donated time, resources, or funds to support the North Texas life science community.
- Mentorship & Inspiration: Inspired and mentored others, fostering the continued growth of the North Texas life science industry.
-
Regional Advocacy: Actively championed the region as a thriving hub for successful life science ventures.
|
Upcoming Events & Opportunities
|
May 2025 Morning Meet-Up
Join NearSouthside for a networking event featuring community news and development updates from the team. We’ll prioritize around-the-room introductions to help you connect with others.
May 7th | Fort Worth, TX
|
Golden Ticket North Texas
Join Ignite Healthcare for an inspiring evening as selected female founders present their groundbreaking digital health and medical device solutions to a panel of industry leaders, investors, and advisors.
May 8th | Dallas, TX
|
BIO BREAK: Fort Worth's Life Sciences Happy Hour
Join BioNTX, RSM, Haynes Boone and UTA for a happy hour dedicated to the life science community—where ideas flourish, partnerships grow, and collaboration thrives.
May 13th | Fort Worth, TX
|
2025 Research & Quality Symposium
Join JPS Health Network for an evening of breakout discussions, poster presentations, a keynote, and a research competition showcasing impactful scholarly work.
May 14th | Fort Worth, TX
|
2025 Building a Life Science Entrepreneurial Ecosystem
Join BioNTX and the UT Tyler School of Medicine to hear groundbreaking research and explores key topics like intellectual property, and entrepreneurial success stories.
May 20th | Tyler, TX
|
2025 TechConnex by USICOC DFW
Join USICOC to be part of the action at the Annual Tech Conference in the heart of the DFW metro area! This event brings together top minds in technology, offering opportunities for networking, learning, and collaboration.
May 22nd | Plano, TX
|
Thank you for your Membership & Support!
"Those who contemplate the beauty of the earth find reserves of strength that will endure as long as life lasts."
- Rachel Carlson
|
|
